Clinical Trial Update: Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk [Phase 2]

View source ↗

Summary

Phase II clinical trial investigating metformin for reducing obesity-associated breast cancer risk has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Breast Cancer Prevention

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: University of Arizona | Conditions: Breast Cancer Prevention | Phase 2 | Status: COMPLETED | Results posted: 2021-03-12